The molecular mechanisms that define the specificity of flavivirus RNA encapsulation are poorly understood. Virions composed of the structural proteins of one flavivirus and the genomic RNA of a heterologous strain can be assembled and have been developed as live attenuated vaccine candidates for several flaviviruses. In this study, we discovered that not all combinations of flavivirus components are possible. While a West Nile virus (WNV) subgenomic RNA could readily be packaged by structural proteins of the DENV2 strain 16681, production of infectious virions with DENV2 strain New Guinea C (NGC) structural proteins was not possible, despite the very high amino acid identity between these viruses. Mutagenesis studies identified a single residue (position 101) of the DENV capsid (C) protein as the determinant for heterologous virus production. C101 is located at the P1= position of the NS2B/3 protease cleavage site at the carboxy terminus of the C protein. WNV NS2B/3 cleavage of the DENV structural polyprotein was possible when a threonine (Thr101 in strain 16681) but not a serine (Ser101 in strain NGC) occupied the P1= position, a finding not predicted by in vitro protease specificity studies. Critically, both serine and threonine were tolerated at the P1= position of WNV capsid. More extensive mutagenesis revealed the importance of flanking residues within the polyprotein in defining the cleavage specificity of the WNV protease. A more detailed understanding of the context dependence of viral protease specificity may aid the development of new protease inhibitors and provide insight into associated patterns of drug resistance. 
W
est Nile virus (WNV) and the four serotypes of dengue virus (DENV1 to -4) are mosquito-borne viruses of the Flavivirus genus that significantly impact public health (1, 2) . Despite a clear need, neither vaccines nor therapeutics for WNV or DENV have been licensed for use in humans. The flavivirus genome is an ϳ11-kb, single-stranded, positive-sense RNA that encodes a single open reading frame flanked by 5= and 3= untranslated regions. The viral genome is translated on endoplasmic reticulum (ER)-derived membranes into a single polyprotein that undergoes co-and posttranslational cleavage by the viral protease NS2B/3 and host proteases into 10 functionally distinct proteins, including the structural proteins capsid (C), premembrane (prM), and envelope (E) that form the virus particle. During assembly, membrane-anchored prM and E glycoproteins are incorporated into virions as they bud into the ER lumen. The C protein associates with the viral genome in the cytoplasm to form an unstructured nucleocapsid that is incorporated into the budding particle via unknown mechanisms (3) . The carboxy terminus (C terminus) of the C protein includes a signal sequence, flanked by protease cleavage sites, that directs the translocation of prM into the ER lumen and tethers C to the cytosolic face of the ER membrane.
Cleavage at both sites is essential for virion morphogenesis and occurs in a sequential manner (4) (5) (6) . NS2B/3 first cleaves the C protein on the cytosolic side, resulting in its release from the membrane and increased exposure of the cleavage site on the luminal side of the ER membrane that is recognized by a cellular signalase. Signalase cleavage remains inefficient until NS2B/3-mediated cleavage has occurred, and uncoupling the coordinated processing of the C protein decreases the nucleocapsid incorporation into virions (7, 8) .
The flavivirus protease is a complex of the viral proteins NS2B and NS3, the latter of which contains the proteolytic domain (9) (10) (11) . NS2B is an essential cofactor that aids in NS3 folding and substrate recognition and contains a hydrophobic domain that tethers the protease to the ER membrane (12, 13) . NS2B/3 cleaves at least five positions within the membrane-associated viral polyprotein in addition to the C protein (9, 14, 15) . Due to its essential role in flavivirus replication, the proteolytic activity of NS2B/3 is an attractive target for the development of antiviral drugs (reviewed by Lin and Shi [16] ). The feasibility of designing flavivirus protease inhibitors is suggested by the successful development of protease inhibitors for hepatitis C virus (HCV), a related hepacivirus in the Flaviviridae family. Numerous HCV protease inhibitors have been approved for treatment of HCV by the FDA (reviewed in reference 17). However, while compounds with inhibitory activity against recombinant flavivirus proteases with activity in cell culture have been described (16, (18) (19) (20) (21) (22) (23) , no compounds with in vivo activity have been described.
The design of peptidic or peptidomimetic inhibitors that bind the active site of viral proteases is informed by a detailed understanding of the specificity of substrate recognition. Alignments of flavivirus NS2B/3 cleavage sites reveal a highly conserved dibasic motif at the P1 and P2 positions (upstream of the cleavage site) and a small-side-chain amino acid (G, A, S, or T) at the P1= position (downstream of the cleavage site), according to the Schechter and Berger nomenclature (24) . This is reflected in the results of substrate specificity profiling studies performed with recombinant proteases of several flaviviruses, including WNV and DENV (25) (26) (27) (28) (29) (30) (31) (32) (33) . However, while considerable insight has been gained from studies with recombinant proteases or model substrates, it is not known how the conditions used in these assays influence cleavage specificity or if they recapitulate the activity of NS2B/3 in infected cells.
In this study, we have identified novel features of WNV protease substrate specificity using a cell culture-based assay. In efforts to produce virus particles by trans complementation, we discovered that the packaging of a WNV subgenomic RNA by DENV structural proteins was strikingly strain dependent. This phenotype was mapped to the substrate specificity of the WNV NS2B/3 protease. WNV NS2B/3 cleavage of the DENV2 C protein was substantially reduced by conservative amino acid substitutions at the P1= position of the cleavage site; cleavage was possible with a glycine or serine but not threonine at this site. In contrast, cleavage of the WNV C protein was efficient with any of the three residues at the P1= position. This fine specificity was not predicted by studies with recombinant NS2B/3 protease and short peptide substrates (33) . We found that the sensitivity of WNV NS2B/3 to changes at the P1= position could be altered when residues at the P6 to P2 and P2= to P4= positions were mutated in various combinations. These findings suggest the context in which the cleavage site is presented has a marked impact on protease recognition and has implications for studies of flavivirus protease specificity and inhibition.
MATERIALS AND METHODS
Cell lines. All cell lines were maintained at 37°C and 7% CO 2 . HEK-293T cells were passaged in Dulbecco's modified Eagle medium (DMEM) containing Glutamax (Invitrogen, Carlsbad, CA), supplemented with 7% fetal bovine serum (FBS) (HyClone, Logan, UT) and 100 U/ml penicillinstreptomycin (PS) (Invitrogen, Carlsbad, CA). Raji cells expressing the C-type lectin DC-SIGNR were passaged in RPMI 1640 medium containing Glutamax (Invitrogen, Carlsbad, CA), supplemented with 7% FBS and 100 U/ml PS.
Plasmids. Plasmids encoding subgenomic replicons of the WNV lineage II strain 956 (herein referred to as WNVrep) and DENV2 strain 16681 (DENVrep) have been described previously (34, 35) ; both were engineered to express a cassette encoding green fluorescent protein (GFP) and containing a gene conferring resistance to Zeocin. Plasmids that express the CprME structural genes of WNV strain NY99, DENV1 strain Western Pacific-74 (WP), and DENV2 strain 16681 have been described previously (34, 35) . Additionally, the CprME structural genes of DENV2 strains New Guinea C (NGC) (GenBank accession no. AAA42941) and IQT2913 (GenBank accession no. AF100468) were cloned into the expression vector pcDNA6.2 (Invitrogen, Carlsbad, CA). Single amino acid mutations were introduced into CprME expression constructs using the Quikchange site-directed mutagenesis kit (Stratagene, La Jolla, CA) according to the manufacturer's instructions. Overlap extension PCR was used to introduce larger numbers of amino acid changes into the NGC CprME C gene, to construct DENV2 NGC/16681 CprME chimeras and to add a V5 tag (GKPIPNPLLGLDST) to the amino terminus of the C protein in NGC and WNV CprME plasmids. All plasmid propagation and cloning procedures were performed using Escherichia coli Stbl2 cells grown at 30°C (Invitrogen, Carlsbad, CA).
Production of RVPs. Reporter virus particles (RVPs) were produced by the genetic complementation of a DNA-launched, subgenomic replicon with a CprME expression plasmid, as described previously (34, 36) . Briefly, preplated HEK-293T cells were cotransfected with replicon and CprME expression plasmids in a 1:3 ratio by mass using Lipofectamine LTX or Lipofectamine 3000 (Invitrogen, Carlsbad, CA) in accordance with the manufacturer's instructions. Transfected cells were incubated in a low-glucose formulation of DMEM containing 25 mM HEPES (Invitrogen, Carlsbad, CA), 7% FBS, and 100 U/ml PS. Transfected cells were incubated at 30°C, and supernatant was harvested at various times posttransfection, filtered using a 0.22-m-pore syringe filter, and stored at Ϫ80°C.
Measuring the infectious titer of RVPs. The infectious titer of RVPs was assayed using Raji cells expressing DC-SIGNR, as described previously (34, 36) . Briefly, serial 2-fold dilutions of RVP-containing supernatant were added to cells, followed by incubation at 37°C for 2 (WNVrep) or 3 (DENVrep) days. Infection was scored by flow cytometry as the percentage of cells expressing GFP. To calculate infectious titers, only values on the linear portion of virus infectivity titrations were used to solve the following equation: IU/sample volume ϭ (% GFP ϩ cells) ϫ (no. of cells) ϫ (dilution factor), where IU represents infectious units.
Quantification of viral RNA. The amount of viral RNA in RVP-containing supernatants was measured by quantitative reverse transcription-PCR (qRT-PCR). Supernatant was treated with recombinant DNase I (Roche Diagnostics, Indianapolis, IN) followed by lysis and RNA isolation (EZ1 virus minikit v2.0; Qiagen, Valencia, CA). RNA content was quantified with the Superscript III one-step RT-PCR system with Platinum Taq DNA polymerase (Invitrogen, Carlsbad, CA) and primers specific for the 3= untranslated region of the WNV lineage II replicon (37) .
Measuring the efficiency of capsid cleavage. To measure the efficiency of C protein cleavage by the WNV or DENV protease, V5-CprME expression constructs were transfected into HEK-293T cells as described above. Two days posttransfection, cells were disrupted using radioimmunoprecipitation assay (RIPA) lysis and extraction buffer (Thermo Scientific, Waltham, MA) supplemented with protease inhibitors (cOmplete mini-protease inhibitor cocktail tablets; Roche Diagnostics, Indianapolis, IN) according to the manufacturers' instructions. The total protein concentration in cell lysates was measured using the Thermo Scientific Pierce bicinchoninic acid (BCA) protein assay kit (Thermo Scientific, Waltham, MA) and used to normalize loading of samples for analysis by SDS-PAGE and Western blotting. Immunoblots were performed using an anti-V5 mouse monoclonal antibody (Invitrogen, Carlsbad, CA) at 1 g/ml, fol-lowed by IRDye 800CW goat anti-mouse IgG (1/2500 dilution) (LiCor, Lincoln, Nebraska). Blots were imaged using a LiCor Odyssey infrared imaging system (LiCor, Lincoln, Nebraska). C protein cleavage was detected by the presence of a band corresponding to the V5-tagged C protein (ϳ13 kDa), while uncleaved C protein was detected by the presence of a band corresponding to CprM (ϳ33 kDa). Cleavage efficiency was quantified by comparing the amount of cleaved C (intensity of 13-kDa band) to total C (13-kDa band intensity plus 33-kDa band intensity). Cleavage efficiency is presented as the percentage of cleaved over total C protein Ϯ 1 standard error of the mean.
Statistical analyses. Statistical analyses were performed using Prism software version 6.0f for Mac OS X (GraphPad Software, San Diego, CA). Log 10 IU per milliliter infectious titer values and cleavage efficiency values were compared by one-way analysis of variance (ANOVA) followed by Tukey's multiple-comparison test.
Surface electrostatic potential calculation. Surface electrostatic potential calculations were done with APBS (38) and pdb2pqr (39, 40) using default parameters (protein dielectric, 2.0; solvent dielectric, 78.0). Images were rendered in PyMOL (41) .
RESULTS
DENV2 strain-dependent complementation of a WNV subgenomic replicon. Pioneering studies by Alexander Khromykh and colleagues demonstrated that subgenomic flavivirus replicon RNAs lacking the structural genes could be encapsidated by CprME proteins expressed in trans (42) . This genetic complementation results in the production of pseudoinfectious virus-like particles capable of only a single round of infection, referred to herein as reporter virus particles (RVPs). RVPs have been used extensively to study flavivirus biology (43) (44) (45) (46) (47) (48) and virus-antibody interactions (35, 36, (49) (50) (51) and as tools to screen antiviral compounds (19, 52, 53) . The mechanism of flavivirus RNA packaging is not well understood and appears to be relatively nonselective. Replicon RNAs of one flavivirus can be packaged by structural genes derived from another flavivirus (34, (54) (55) (56) . Additionally, several flavivirus vaccine candidates are chimeric viruses in which the structural proteins of one virus are inserted into the genomic background of a heterologous virus type (reviewed by Ishikawa et al. [57] ). To study mechanisms of flavivirus neutralization, our laboratory has produced RVPs by complementation of a WNV replicon (WNVrep) with structural genes derived from WNV, DENV, and the tick-borne flavivirus Langat (34, 35, 44) . In particular, high-titer RVP stocks have been generated by complementation of WNVrep with the structural genes of DENV2 strain 16681 (34, 58) .
To expand the DENV2 strains available for study using this approach, we generated CprME structural gene constructs for the strains New Guinea C (NGC) and IQT2913. DENV2 NGC is the strain from which the DENV2 component of the NIAID tetravalent vaccine candidate was derived (59) . IQT2913 is an isolate from Iquitos, Peru (60) . Figure 1A shows RVP titers generated by complementation of the WNV replicon with CprME from DENV2 NGC and IQT2913, as well as from flaviviruses previously shown to result in infectious RVPs (DENV2 16681, DENV1 Western Pacific-74 [WP] , and the NY99 strain of WNV). Complementation with CprME from WNV, DENV1, and DENV2 16681 produced comparable RVP titers that peaked ϳ72 to 96 h posttransfection, similar to previous observations (34) . Mean titers for WNV, DENV1, and DENV2 16681 RVPs collected at 72 h posttransfection ranged from 1 ϫ 10 6 to 4 ϫ 10 6 IU/ml (n ϭ 3) (Fig.  1B) . Conversely, complementation of the WNV replicon with CprME from DENV2 strains NGC and IQT2913 resulted in no detectable RVP production (n ϭ 3) (Fig. 1A and B) . These results were surprising, as DENV2 16681 shares 98% and 97% amino acid identity with strains NGC and IQT2913, differing by 17 and 24 amino acid residues within CprME, respectively. Analysis of the RNA content of DENV2 NGC and IQT2913 RVP preparations revealed Ͼ1,000-fold lower RNA content than DENV2 16681 RVP-containing supernatants produced in parallel (n ϭ 3) (Fig.  1C) . Thus, the inability to complement the WNV replicon with structural genes from DENV2 strains NGC or IQT2913 reflected a defect prior to the release of virus particles into the supernatant.
We next performed complementation experiments with a DENV2 subgenomic replicon of similar design (DENVrep). RVPs produced using this replicon resulted in comparable titers for all three DENV2 strains (16681, NGC, and IQT2913), with mean titers ranging from 1 ϫ 10 5 to 5 ϫ 10 5 IU/ml at 120 h posttransfection (n ϭ 3) (Fig. 1D and E) . As noted previously (34) , RVP production using the DENV replicon was delayed (Fig. 1A versus D) and less efficient (Fig. 1B versus E) compared to that in experiments with WNVrep.
The C protein governs DENV2 RVP production following WNV replicon complementation. To determine the molecular basis of the DENV2 strain-specific RVP production, we created chimeras of DENV2 16681 and DENV2 NGC structural proteins ( Fig. 2A) . Each chimera was evaluated in complementation experiments with the WNV replicon. RVP production studies revealed that all CprME chimeras containing the C gene of 16681, regardless of the origin of the prM or E genes, resulted in robust RVP titers (mean titers of Ͼ10 5 IU/ml [n ϭ 3]). In contrast, all CprME chimeras containing the NGC C gene resulted in undetectable RVP production (n ϭ 3) (Fig. 2B) . These data reveal a critical role for the C protein in modulating DENV2 RVP production using a heterologous viral RNA.
The C proteins of DENV2 16681 and NGC differ at only two amino acid residues (residues 9 and 101). We created NGC variants encoding a single substitution at these positions to correspond to the amino acid found in 16681 and evaluated them in RVP production experiments with WNVrep. Complementation with wild-type (WT) NGC and the NGC R9K variant resulted in undetectable RVP titers (n ϭ 3). In contrast, the T101S mutation in the NGC background resulted in RVP production similar to titers obtained with 16681 (Ͼ10 5 IU/ml [n ϭ 3]; P ϭ 0.36) (Fig.  2C) . A similar pattern was observed following the introduction of mutation T101S into the DENV2 IQT2913 C protein (data not shown). Conversely, the reciprocal S101T mutation in the 16681 C protein rendered this construct incapable of RVP production following complementation of the WNV replicon (Fig. 2D) . Together, these results identify C protein residue 101 as the determinant of compatibility between the structural genes of DENV2 and a WNV replicon RNA during virus particle production.
WNV NS2B/3 cannot cleave the DENV2 C protein when a threonine occupies the P1= position. During polyprotein processing, NS2B/3 cleaves the C protein immediately after residue 100, removing the C-terminal signal sequence and liberating it from its membrane anchor. C protein residue 101 identified above is located immediately downstream of the scissile bond in the P1= position of the cleavage site (Fig. 2E) and therefore has the potential to impact cleavage by the WNV protease. To investigate this hypothesis, we developed an assay to measure C protein cleavage in cells harboring a replicating flavivirus subgenomic RNA. A V5 tag was inserted at the amino terminus of the C protein in DENV2 NGC CprME expression constructs (V5-CprME), enabling quantitation of NS2B/3 cleavage efficiency in RVP-producing cells by Western blotting. Using this system, capsid cleavage resulted in the production of a V5-tagged C protein that is considerably smaller than its uncleaved C-prM precursor (13 kDa and 33 kDa, respectively). Cleavage studies in HEK293T cells cotransfected with the WNV replicon and WT NGC CprME genes resulted in no detectable cleaved C protein in cell lysates. In contrast, partial cleavage of NGC T101S (the 16681 P1= residue) and NGC T101G (the WNV P1= residue) was observed in experiments performed in parallel (31% Ϯ 16% and 63% Ϯ 12%, respectively [n ϭ 4]) ( Fig.  3A and B) . These results correlated well with the ability of these structural gene constructs to produce infectious RVPs by complementation (Fig. 3C versus Fig. 1B and E) . RVP production with the WT NGC V5-CprME construct resulted in undetectable titers, whereas NGC constructs with T101S or T101G mutations at the P1= site enabled efficient RVP release (Ͼ10 5 IU/ml [n ϭ 2]). By comparison, cleavage experiments using the DENV replicon resulted in efficient cleavage of the C protein regardless of whether the amino acid at residue 101 was a T, S, or G (Ͼ90% cleaved C [n ϭ 4]) (Fig. 3A and B) . RVP titers in the corresponding supernatants were similar for all three structural gene constructs (ϳ3 ϫ 10 3 IU/ml [n ϭ 2]). These results demonstrated that even chemically conservative amino acid variation at the P1= position modulates cleavage of the DENV C protein and RVP production in cells replicating a WNV replicon.
WNV NS2B/3 efficiently cleaves the WNV C protein when a threonine occupies the P1= position. Because a T residue in the P1= position of the DENV2 NGC C protein cleavage site prevents processing by the WNV NS2B/3 protease, we hypothesized that introduction of a T into the P1= position (residue 106) of the WNV C protein cleavage site would have a similar phenotype. Surprisingly, complementation of the WNV replicon with a WNV G106T variant resulted in efficient RVP production (3 ϫ 10 6 IU/ml [n ϭ 3]) (Fig. 4A) , with only a 0.5-log reduction in titer compared to WT WNV (P ϭ 0.015 [n ϭ 3]). Likewise, a WNV G106S variant also supported RVP titers similar to WT WNV (P ϭ 0.18 [n ϭ 3]). Biochemical studies revealed that the levels of WNV protease cleavage efficiency of all three constructs were similar ( Fig. 4B and C) (n ϭ 3; P Ͼ 0.05 for all comparisons). Altogether, these data demonstrate that a threonine in the P1= position of the C protein cleavage site impacts WNV NS2B/3 protease efficiency in a strikingly context-dependent manner.
The specificity of WNV NS2B/3 at the P1= position is influenced by surrounding residues. We next investigated how the sequence surrounding the protease cleavage site affected WNV protease specificity at the P1= position. We replaced residues adjacent to the incompatible threonine at the P1= position of NGC capsid with those corresponding to the WNV capsid (Fig. 5A) . Cleavage of each NGC C protein variant was measured by Western blotting of cells expressing the WNV replicon; the efficiently cleaved NGC T101G variant was used as a positive control in these studies. Efficient cleavage was observed when positions P4 to P2= (55% Ϯ 9%) and P6 to P4= (86% Ϯ 6%) were mutated ( Fig. 5B  and C) . Mutations at residues flanking just one side of the cleavage site were poorly cleaved (14% Ϯ 3% and 13% Ϯ 7% for mutants P2=-10= and P10-P2, respectively). Notably, the cleaved C protein of mutant P2=-P10= migrated more slowly during gel electrophoresis than C protein expressed from other NGC constructs (Fig.  5B) . In this construct, the order of cleavage may be uncoupled by mutations within the signal sequence, which have the potential to impact the display of the capsid-signal sequence junction and result in a cleaved C protein that retains a C-terminal signal sequence (8). As detailed above, the efficiency of C protein cleavage directly impacted the release of infectious virus particles. The relatively efficiently cleaved capsid variants supported virus production, including NGC T101G (9 ϫ 10 5 IU/ml), mutant P4=-P2= (7 ϫ 10 4 IU/ml [13-fold reduction from T101G]), and mutant P6-P4= (9 ϫ 10 4 IU/ml [10-fold reduction from T101G]), while low-to-undetectable titers for mutants P2=-10= and P10-P2 (Ͻ10 2 IU/ml) were achieved (Fig. 5D) . These results suggest that amino acids directly surrounding the cleavage site influence the ability of WNV NS2B/3 to cleave a substrate when a T occupies the P1= position.
Our data suggested that the ability of WNV NS2B/3 to cleave DENV C proteins with a threonine at the P1= position can be influenced by residues between P4 and P2=. Therefore, we constructed NGC C protein variants with single amino acid substitutions (at the P4, P3, P2, or P2= position) to determine if individual substitutions influence WNV NS2B/3 specificity. Unlike the efficient C protein cleavage detected for NGC mutant P4-P2= encoding four mutations (Fig. 5C ), minimal cleavage of variants with a single mutation at either P4, P3, P2, or P2= was observed (n ϭ 3, P Ͼ 0.25 for WT NGC versus each mutant) (Fig. 5E and F) . Notably, among these constructs, the C protein of the P2= mutant was most efficiently cleaved (10% Ϯ 3%) (Fig. 5F ) and supported RVP (Fig. 5G) to levels similar to that observed when multiple residues were changed (mutants P6-P4= and P4-P2=) (Fig. 5D) .
The difference in cleavage efficiencies of the P6-P4= and P4-P2= variants (Fig. 5D ) suggests a role for residues farther from the scissile bond studied above. Of interest, the P5 and P3= residues differ in charge between WNV and DENV. We constructed additional NGC C protein variants with single amino acid substitutions at the P6, P5, P3=, and P4= positions and evaluated the efficiency of C protein cleavage following complementation with the WNV replicon. Complementation with mutants P6 and P4= resulted in inefficient cleavage (4% Ϯ 1% and 9% Ϯ 5%, respectively) (Fig. 5H and I ) and low but detectable RVP titers (7 ϫ 10 3 IU/ml and 3 ϫ 10 4 IU/ml; 59-and 15-fold reductions from T101G titers for mutants P6 and P4=, respectively) (Fig. 5J ). For mutants P5 and P3=, neither cleaved C protein nor infectious RVPs were detectable ( Fig. 5H to J) . Altogether, these results indicate that the interactions that mediate WNV NS2B/3 specificity for the P1= site involve multiple surrounding residues. Mutations at the P6, P2=, and P4= positions individually had a minor effect on C protein cleavage compared to multiple mutations at the P6 to P4= and P4 to P2= positions.
DISCUSSION
Little is known about the specificity of the flavivirus NS2B/3 protease in the context of viral RNA replication or authentic viral polyprotein substrates (61) . Most studies to define protease cleavage site specificity employ short (3-to 8-amino-acid) synthetic peptide substrates and covalently linked and truncated forms of NS2B and NS3 (25) (26) (27) (28) (29) (30) (31) (32) (33) . Furthermore, these experiments are performed in the absence of membranes, at basic pH (ϳpH 9), and in the presence of detergents and high concentrations of glycerol.
These biochemical approaches have identified a requirement for dibasic residues at P1 and P2 and a small side chain at the P1= position of the cleavage site, although preferences for particular residues within that motif exist, and distinct specificities have been of WNV, DENV2 NGC, and DENV2 NGC mutants. Highlighted in gray is the P1= residue; highlighted in black are the substitutions from the WNV cleavage site introduced into each variant. The numbering at the top corresponds to the location in the DENV2 NGC C protein amino acid sequence. (B to J) V5-tagged CprME constructs of DENV2 NGC containing a mutation at the indicated C protein cleavage site were used in complementation experiments with WNVrep. Cell lysates were collected and analyzed by SDS-PAGE and subjected to Western blotting with an anti-V5 MAb. For the NGC variants from panel A, shown is a representative blot (B), with the mean efficiency of C protein cleavage (C) and mean infectious RVP titer (D) from four independent experiments. Error bars represent the standard error of the mean. For mutants P4, P3, P2, and P2=, shown is a representative blot (E), with the mean efficiency of C protein cleavage (F) and mean infectious RVP titer (G) from three independent experiments. Error bars represent the standard error of the mean. For mutants P6, P5, P3=, and P4=, shown is a representative blot (H), with the mean efficiency of C protein cleavage (I) and mean infectious RVP titer (J) from three independent experiments. Error bars represent the standard error of the mean. noted between viruses. WNV NS2B/3 has been shown to preferentially cleave sites with a K at P2, whereas DENV NS2B/3 most efficiently cleaves sites with an R at this position. In contrast, WNV and DENV NS2B/3 proteases both preferentially cleave sites with an R over a K at the P1 position (25, 33, 62) . These studies have indicated that WNV NS2B/3 has a strict preference for G at both the P1= and P2= positions, while DENV NS2B/3 is less selective and can cleave substrates with almost any amino acid at P1= and P2= (33) . Another study, however, observed a narrower specificity of the DENV protease at the P1= position (restricted to small, polar amino acids with a strong preference for S) and at the P2= position (a weak preference for acidic residues) (62) .
How substrate residues outside the active site recognition site impact cleavage efficiency has not been well explored for flavivirus proteases. Allosteric and subsite cooperativities have the potential to influence protease substrate specificity (reviewed by Ng et al. [63] ). Allosteric cooperativity occurs when the binding of substrate residues to a protease outside the active site affects proteolytic efficiency. Subsite cooperativity posits that individual subsite binding may be positively or negatively influenced by binding of surrounding subsites (reviewed in reference 63). Both processes have been shown to contribute to HIV-1 protease recognition (64-67). As discussed above, prior studies of the WNV NS2B/3 employed short peptide substrates that do not extend significantly beyond the active site, potentially limiting their utility for identifying all of the interactions that impact protease specificity.
To investigate the effect of cleavage site context on WNV NS2B/3 substrate specificity, we studied WNV NS2B/3 processing of DENV and WNV C proteins. WNV NS2B/3 cleaved the DENV2 C protein when a G, but not a T, occupied the P1= position. In contrast, when the P1= residue of the WNV C protein cleavage site was mutated from a G to a T, we observed efficient WNV NS2B/3 cleavage, indicating that a T at P1= is permissive for cleavage only in the context of certain substrates. This context-dependent cleavage specificity could be a result of either allosteric or subsite cooperativity (or both), as the WNV and DENV2 C proteins have sequence differences at residues both within and outside the protease binding site.
To study the effect of subsite cooperativity on WNV protease specificity, we introduced mutations in a DENV2 CprME construct at residues surrounding the C protein cleavage site. While keeping a T constant at the P1= position (which results in uncleaved C protein in the context of the WT DENV2 NGC sequence), surrounding residues were mutated to match the WNV C protein cleavage site. We found that WNV NS2B/3 was able to efficiently cleave the DENV2 C protein containing a T at the P1= position when the P4, P3, P2, and P2= positions were mutated simultaneously. When the P6, P5, P3=, and P4= positions were additionally mutated, cleavage efficiency was further enhanced. Thus, the sequence context within the active site binding site of the substrate greatly impacts WNV NS2B/3 specificity for the P1= residue. However, when the P6, P5, P4, P3, P2, P2=, P3=, and P4= mutations were introduced separately, their effect on the efficiency of DENV2 C protein cleavage by the WNV protease was greatly diminished. Thus, the interactions that mediate the context-dependent specificity of WNV NS2B/3 at the P1= position are likely due to the influence of multiple substrate residues.
Notably, one in vitro study observed strict specificity of WNV NS2B/3 for a G at P1= (33) . This finding is not consistent with the observation that, while most WNV NS2B/3 cleavage sites do contain a G at P1=, the P1= position of the cleavage site at the NS3/ NS4A junction is occupied by an S. It also contradicts our finding that the WNV and DENV2 C proteins were cleaved by the WNV protease when an S occupied the P1= position. Several differences in experimental design between the studies could account for this discrepancy, including assay conditions (biochemical versus cellbased assay), NS2B/3 source (recombinant, truncated NS2B/3 versus full-length NS2B/3 from the polyprotein), and the substrate used to probe specificity (9-mer peptides versus a CprME polyprotein).
Structural basis for WNV NS2B/3 substrate specificity. Efficient peptide cleavage requires accurate placement of the scissile peptide bond in the active site. A view of substrate binding is available in crystal structures for inhibitor-bound WNV NS2B/3 (13, 68, 69) and DENV NS2B/3 (70) . The pocket in NS2B/3 occupied by the substrate P1= side chain (the S1= subsite) is lined by the side chains of NS3 residue 36 (DENV I36, WNV A36) and the catalytic histidine (NS3 H51) (13) . In structures of both WNV and DENV NS2B/3, the P1= side chain of a protein inhibitor binds identically to the small and relatively hydrophobic S1= subsite (13, 70) . In contrast, the S2= subsite for the substrate P2= side chain is a large, open pocket on the enzyme surface between the side chains of NS3 residues 34 and 131. Here the structures differ (NS3 Y34 in WNV versus T34 in DENV; NS3 P131 in WNV versus K131 in DENV). The structures are consistent with the data presented herein that substrate sequences flanking the cleavage site play a role in specificity (70) . Our data are also consistent with other observations that NS3 positions 131 and 132 contribute to specificity of the P2= position, as mutation of WNV NS3 P131 and NS3 T132 to match the DENV sequence (P131K plus T132P) shifted the specificity of WNV NS2B/3 to that of DENV NS2B/3 (71) . Interactions between protease and substrate on the non-prime site of the scissile bond involve the S2 and S3 pockets of the active site and are occupied by the P2 and P3 positions of the substrate, respectively. Like the situation for the substrate P1= site, the substrate P2 and P3 side chains bind WNV and DENV NS3 identically in the S2 and S3 subsites (13, 69) . Substrate-enzyme interactions well beyond the scissile bond and/or cooperativity of subsites are clearly critical.
The subsite cooperativity observed in our study may be a result of restrictions on substrate size by WNV NS2B/3, where the WNV NS2B/3 preference for the smaller substrate residues at P1= (G Ͼ T) and P2 (K Ͼ R) can be overcome by the introduction of smaller residues at neighboring positions. We have shown that WNV NS2B/3 cleavage of substrates with a T in the P1= position is dependent on the surrounding residues. Notably, when the P4, P3, P2, and P2= positions were mutated to the smaller but chemically similar amino acids found in the WNV C protein cleavage site, WNV NS2B/3 could cleave the DENV2 NGC C protein substrate with a P1= threonine.
Our data together with the available structures show that proper positioning of the peptide substrate is influenced by NS3 interaction with flanking residues at a distance of up to six N-terminal positions and four C-terminal positions of the target peptide bond. Although partial activity can be restored with a single substitution at the P1= site, efficient cleavage of natural substrate requires multiple substrate-enzyme interactions. Consistent with our data, WNV and DENV NS2B/3 structures have strikingly different electrostatic surface potentials near the active site (Fig. 6) . WNV NS2B/3 has a more negatively charged surface in the region surrounding the substrate entrance, while DENV NS2B/3 has a more electropositive surface. The more negative surface of WNV NS2B/3 outside the active site may account for the increased cleavage efficiency we observed when the P6, P5, P3=, and P4= positions were mutated in addition to the P4 to P2= positions in NGC mutant P6 to P4=, as the P5 and P3= positions now contained positively charged lysine residues. While individual mutations at P5 and P3= did not have an effect on WNV NS2B/3 cleavage of the NGC C protein, cooperative effects from multiple residues surrounding the cleavage site could mediate cleavage.
Our results indicate that subsite cooperativity involving multiple residues within the P6 to P2 and P2= to P4= positions influences the specificity of the WNV protease at the P1= position. This finding has implications for the design of experiments to probe NS2B/3 substrate specificity, as the substrate selected for specificity profiling may drastically affect the results of the screen. Furthermore, molecular details of substrate specificity can be integrated with structural information to facilitate rational inhibitor design.
